Massive Bio

About Massive Bio

Massive Bio operates an AI-powered platform that connects cancer patients and their oncologists to clinical trials. The company's service is designed to streamline the search process for treatment options by using machine learning and artificial intelligence to analyze a patient's medical records and identify suitable clinical trials. This service is provided free of charge to patients. The business model appears to be centered around providing pharmaceutical companies with access to a pre-screened pool of patients for their clinical trials, thus accelerating patient recruitment. The company serves individual cancer patients and their doctors, as well as pharmaceutical companies conducting oncology research. The market is the global oncology clinical trial industry. By combining technology with physician expertise, the company aims to improve patient access to next-generation cancer therapies. The platform functions as a clinical trial matching system, aiming to reduce the time and complexity involved in finding appropriate trials for cancer patients. This approach also provides value to biopharmaceutical companies by optimizing their patient recruitment process for clinical studies. The company has stated its commitment to ensuring patients have equal access to advanced therapies and clinical trials, regardless of their location or financial situation.